Ozempic, Chronic Kidney Disease, and Diabetes
In January 2025, the FDA approved Ozempic (semaglutide) to help treat patients with chronic kidney disease and diabetes. Semaglutide belongs to a group of drugs called glucagon-like peptide-1 receptor agonists (GLP1-RAs), which were originally approved to help control blood sugar in people with type 2 diabetes. Other forms of GLP1-RAs include Mounjaro, Wegovy, semaglutide, and […]
Are Your Kidneys OK?
The human body can manage with reduced kidney function for a long time, often without showing any signs. This is why World Kidney Day 2025’s theme is, Are Your Kidneys OK? Detect early and protect kidney health. While chronic kidney disease has no cure, if it is caught early enough, measures can be taken to […]
News: Zepbound (tirzepatide) Approved to Treat Obstructive Sleep Apnea
The weight-loss drug Zepbound is the first FDA-approved prescription medicine to help treat obstructive sleep apnea (OSA). Zepbound, or tirzepatide, originally received approval in November 2023 to treat obesity. It’s now a new rival to Novo Nordisk’s popular drug, Wegovy. The FDA has now given the green light for tirzepatide to treat obstructive sleep apnea […]
Semaglutide Has Done it Again for Knee Osteoarthritis
Drug trials involving human test subjects always involve some level of dropout. Dropout refers to how many subjects stopped participating before the planned end date – for any reason. In most instances, the level of dropout has negative connotations because it means that the subjects were either experiencing intolerable side effects or were not sticking […]
Natural GLP-1 Supplements: Do They Match Wegovy’s Power?
With the rising popularity of weight-loss drugs, some wellness companies are promoting supplements that they claim can boost the levels of natural GLP-1 that can control hunger and promote weight loss. These products target people who are looking for a weight loss solution that isn’t as expensive as GLP-1 injections, which in most cases are […]
Bye Bye BMI?
As we approach Healthy Weight Week in January, I recently went back over our published material relating to the subject of weight. This was both from the perspective of how many conditions can be triggered by the fact that people are no longer eating well and also, on the brighter side, that thanks to the […]
Using Nutrition to Offset GLP-1 Side Effects
Glucagon-like peptide-1 (GLP-1) drugs like Ozempic and Wegovy are among the latest innovations in diabetes and weight management. However, they do come with some commonly experienced side effects for users. Happily, I can advise about some nutritional changes that can work to reduce these side effects while also enhancing the efficacy of the medications. GLP-1 […]
How to Tackle Childhood Obesity Without Fueling Eating Disorders
The American Academy of Pediatrics (AAP) recently changed its approach to tackling childhood obesity, moving away from a “wait and see” method to more aggressive treatments for weight loss. This includes recommending bariatric surgery for some teens, medication like Wegovy, and intensive therapy for young children. The AAP claimed these methods wouldn’t lead to eating […]
There’s growing confidence that GLP-1 meds are safe in pregnant women
One of the most frequent cautions that drug companies print on the Product Information leaflet that comes with their product says something like, “This medication has not been tested to be safe in pregnant women and should only be used in consultation with a healthcare provider.” It’s important to understand that this statement is not […]
Treating Obstructive Sleep Apnea with Tirzepatide
Interrupted breathing during sleep, technically known as Obstructive Sleep Apnea (OSA), is a fairly common problem that has, until now, been difficult to address with pharmaceutical treatment. OSA has one quite special characteristic, in that people living with the condition often don’t know that they have it because it occurs only when they are sound […]
